ACCELERON PHARMA INC.

(XLRN)
End-of-day quote Nasdaq  -  11-18
178.75 USD   -0.52%
2021GLOBAL MARKETS LIVE : Airbus, BP, Merck, Pfizer, Meta...
2021Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
DJ
2021ACCELERON PHARMA INC.(NASDAQGM : XLRN) dropped from NASDAQ Biotechnology Index
CI
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on ACCELERON PHARMA INC.
2021ACCELERON PHARMA : Jefferies Starts Acceleron Pharma at Hold With $180 Price Target
MT
2021ACCELERON PHARMA : Raymond James Downgrades Acceleron Pharma to Market Perform From Strong..
MT
2021ACCELERON PHARMA : Oppenheimer Suspends Rating for Acceleron Pharma, $160 Price Target on ..
MT
2021ACCELERON PHARMA : Morgan Stanley Downgrades Acceleron Pharma to Equalweight from Overweig..
MT
2021ACCELERON PHARMA : Barclays Downgrades Acceleron Pharma to Equal-Weight Rating From Overwe..
MT
2021ACCELERON PHARMA : Cowen Downgrades Acceleron Pharma to Market Perform from Outperform, Bo..
MT
2021ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,..
2021ACCELERON PHARMA : HC Wainwright Downgrades Acceleron Pharma to Neutral Rating From Buy, A..
MT
2021ACCELERON PHARMA : RBC Capital Again Raises Price Target for Acceleron Pharma to $180 From..
MT
2021ACCELERON PHARMA : SVB Leerink Adjusts Acceleron Pharma PT to $180 from $148, Keeps Market..
MT
2021ACCELERON PHARMA : Piper Sandler Downgrades Acceleron Pharma to Neutral from Overweight, A..
MT
2021ACCELERON PHARMA : RBC Boosts Price Target on Acceleron Pharma to $179 From $113, Citing D..
MT
2021ACCELERON PHARMA : RBC Raises Price Target on Acceleron Pharma to $113 From $111, Reiterat..
MT
2021ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku...
2021ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma PT to $160 From $141, Maintains Ou..
MT
2021ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma PT to $141 From $140, Maintains Ou..
MT
2021ACCELERON PHARMA : SVB Leerink Downgrades Acceleron Pharma to Market Perform From Outperfo..
MT
2021ACCELERON PHARMA : Goldman Sachs Analyst Assumes Coverage of Acceleron Pharma With Neutral..
MT
2021ACCELERON PHARMA : Wolfe Research Starts Acceleron Pharma at Outperform With $200 Price Ta..
MT
2021ACCELERON PHARMA : Citigroup Adjusts Acceleron Pharma's Price Target to $171 from $137, Ke..
MT
2021ACCELERON PHARMA : SVB Leerink Adjusts Price Target on Acceleron Pharma to $148 From $138,..
MT
2021ACCELERON PHARMA : Morgan Stanley Adjusts Acceleron Pharma PT to $145 From $135, Maintains..
MT
2021ACCELERON PHARMA : JP Morgan Adjusts Acceleron Pharma's Price Target to $153 from $133, Ke..
MT
2020ACCELERON PHARMA : Barclays Adjusts Acceleron Pharma PT to $150 From $133, Maintains Overw..
MT
2020ACCELERON PHARMA : Morgan Stanley Adjusts Acceleron Pharma PT to $135 From $130, Maintains..
MT
2020ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma's Price Target to $131 from $120 o..
MT
2020ACCELERON PHARMA : Oppenheimer Adjusts Acceleron Pharma's Price Target to $120 From $126, ..
MT
2020ACCELERON PHARMA : HC Wainwright Adjusts Acceleron Pharma's Price Target to $148 From $137..
MT